Work with Able Health to track performance for MIPS and submit data to CMS
Able Health calculates quality measures using patient-level data from EHRs, claims, and other sources. Easily enter performance data for Cost, Advancing Care Information, and Improvement Activities to track your MIPS Composite Performance Score over time. If you are participating in a MIPS APM, Able Health can replace MIPS measures with applicable measures from your APM.
In-app tooltips and articles explain how measures are calculated, how to form a valid quality measure set, how the Composite Score is calculated, and more—when and where you need it. Our guidance can reduce the cost of training, time to research requirements, and the negative impact of potential mistakes.
Identify clinicians and patients who need your attention—and take action to improve performance. Deliver scorecards to clinicians, including patient-level measure results and EHR source records. Generate call lists of patients who need care, including specific actions required for each patient.
Submit data across the four performance categories to CMS via the Able Health Qualified Registry. When you track performance throughout the year, end-of-year reporting becomes a simpler—and cheaper—task.
Able Health can calculate and submit all registry measures in the General Oncology specialty-specific measure set, which are listed below.
|374||Closing the Referral Loop: Receipt of Specialist Report||Process||Yes|
|130||Documentation of Current Medications in the Medical Record||Process||Yes|
|449||HER2 Negative or Undocumented Breast Cancer Patients Spared Treatment with HER2-Targeted Therapies||Process||Yes|
|451||KRAS Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy||Process||No|
|143||Oncology: Medical and Radiation - Pain Intensity Quantified||Process||Yes|
|452||Patients with Metastatic Colorectal Cancer and KRAS Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies||Process||Yes|
|317||Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented||Process||No|
|226||Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention||Process||No|
|431||Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling||Process||No|
|457||Proportion Admitted to Hospice for less than 3 days||Outcome||Yes|
|455||Proportion Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life||Outcome||Yes|
|456||Proportion Not Admitted To Hospice||Process||Yes|
|454||Proportion of Patients who Died from Cancer with more than One Emergency Department Visit in the Last 30 Days of Life||Outcome||Yes|
|453||Proportion Receiving Chemotherapy in the Last 14 Days of Life||Process||Yes|
|102||Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients||Process||Yes|
|250||Radical Prostatectomy Pathology Reporting||Process||No|
|402||Tobacco Use and Help with Quitting Among Adolescents||Process||No|
|450||Trastuzumab Received By Patients With AJCC Stage I (T1c) - III And HER2 Positive Breast Cancer Receiving Adjuvant Chemotherapy||Process||Yes|
Select your specialty to find MIPS measures supported by Able Health relevant to your specialty.
|Electrophysiology Cardiac Specialist|
|General Practice/Family Medicine|